NEW MATERIAL:A compound expressed by formula I [R1 is H, OH, SH, 2W20C alkanoyl-O-, 2W20C alkanoyl-S-, etc.; R2 is H or 1W20C alkyl; R3 is formula II (n is integer of 10W14; m is integer of 8W12); R4 is 2W4C alkanoyl; iso-Glu is represented by formula III].
EXAMPLE: N-[2-O-{2-Acetamide-2,3-dideoxy-6-O-[(3R)3-dodecanoyloxytetrade- canoyl]-D-glucopyranos-3-yl}-D-lactoyl]-L-alanyl-D-isoglutamine methyl ester.
USE: An immunomodulation agent.
PREPARATION: For example, (3R)-3-dodecanoyloxytetradecanoic acid is added to DMF solution of a glucopyranos derivative expressed by formula IV (X is hydroxy-protecting group), reacted in the presence of a condensation agent, hydrogenated using Pd catalyst and subjected to the removal of the protecting groups to provide the aimed compound of formula I.
HASEGAWA AKIRA
Next Patent: HUMAN CANCER NUCLEOLUS ANTIBODY AND ITS PURIFICATION